Alirocumab reduces total nonfatal cardiovascular and fatal events the ODYSSEY OUTCOMES trial - Szarek, Michael; White, Harvey D; Schwartz, Gregory G; Alings, Marco; Bhatt, Deepak L; Bittner, Vera A; Chiang, Chern-En; Diaz, Rafael; Edelberg, Jay M; Nicolau, José Carlos (Journal of the american college of cardiology, 2019)